Showing results (1351-1360 of 1,512) with videos related to
Sort By:
Pageof 152
Aging Cell|September 4, 2025
APOE4 Exacerbates Alzheimer-Like Pathologies and Cognitive Deficits Induced by Blood-Derived Aβ in a Mouse ModelZhong-Yuan Yu, Xiao-Yu Liu, Qiong-Yan Li, et al.Theranostics|September 15, 2020
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinomaChanghee Park, Kwon Joong Na, Hongyoon Choi, et al.Endoscopic Ultrasound|February 17, 2018
Patient perception and preference of EUS-guided drainage over percutaneous drainage when endoscopic transpapillary biliary drainage fails: An international multicenter surveyKwangwoo Nam, Dong Uk Kim, Tae Hoon Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2018
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung CancerYi-Long Wu, Li Zhang, Dong-Wan Kim, et al.Clinical Lung Cancer|June 29, 2025
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation StatusLyudmila Bazhenova, J G Hodgson, D Ross Camidge, et al.Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|June 16, 2025
World Endoscopy Organization guidelines on endoscopic retrograde cholangiopancreatography biliary cannulation and sphincterotomy techniquesStefano Francesco Crinò, Lars Aabakken, Amol Bapaye, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2005
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinibSae-Won Han, Tae-You Kim, Pil Gyu Hwang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global StudySai-Hong Ignatius Ou, Jin Seok Ahn, Luigi De Petris, et al.Journal of Alzheimer'S Disease : JAD|February 13, 2023
Associations Between Plasma Klotho with Renal Function and Cerebrospinal Fluid Amyloid-β Levels in Alzheimer's Disease: The Chongqing Ageing & Dementia StudyJun-Rong Ren, Zhen Wang, Yuan Cheng, et al.Kidney Research and Clinical Practice|November 16, 2021
Long-term risk of all-cause mortality in live kidney donors: a matched cohort studyEunjeong Kang, Sehoon Park, Jina Park, et al.Pageof 152